Why are Ketamine Infusions the Next Step in Pain Management?
Ketamine is approved by the U.S. Food and Drug Administration (FDA) for the induction and maintenance of anesthesia and has been safely used in the surgical arena for over 50 years. Mounting evidence generated by many clinical trials and studies has shown Ketamine to be very effective in the management of treatment resistant chronic pain syndromes and psychiatric disorders, providing promise that FDA approval for its use in these situations may be granted in the near future.
Ketamine Infusions should be considered when patients respond poorly to opioids, have a history of high opioid consumption, hyperalgesia, and neuropathic pain. Ketamine Infusions should also be considered when patients with major depressive disorder fail to respond to two pharmacological agents of different classes.
Medical researchers and experts strongly promote ketamine as an effective therapy for treatment-resistant depression and chronic pain. In the capable hands of a healthcare professional, it holds promise for patients who have exhausted every other medical treatment for their condition.
The Medical Benefits of Ketamine for Depression and Pain
Ketamine is ideal for many patients suffering from pain and depression disorders because of its pharmacological properties. Ketamine blocks N-methyl-D-aspartate, or NMDA, a chemical receptor for glutamate, the excitatory amino acid in the brain. It’s ability to regulate neuro transmission at the spinal level has also been documented. Ketamine is responsible for initiating a cascade of events at the cellular level, resulting in tissue repair and anti-inflammation. The drug’s utility in the treatment of mood disorders is related to the ability of Ketamine to generate increased structural connectivity between neurons, particularly in the pre-frontal cortex. Ketamine’s effects in chronic pain, and as an antidepressant, far outlast the actual drug levels.
IV ketamine infusions are administered in small doses in a clinical setting by medical experts. Infusions last on average one hour, and many patients experience some relief after their first treatment. In addition, unlike traditional painkillers and mood stabilizers, there are few side effects with ketamine infusions. Depending on the severity of the condition, patients may only need a few infusions, and treatment can last several months.
Meet WeCare – The First Ketamine Infusion Clinic in St. Louis
While ketamine infusion clinics have been improving lives throughout the country, the St. Louis region, including Central and Southern Illinois, has been left without a resource for patients with treatment-resistant conditions. WeCare in Maryville, IL is the first IV ketamine clinic in the metropolitan area and a St. Louis leader in ketamine therapy. The medical specialists at WeCare are focused on the delivery of patient care by improving quality of life, one patient at a time. For more information, contact our medical team at 618-205-1430.